CSTA, cystatin A, 1475

N. diseases: 97; N. variants: 6
Disease: Prostate carcinoma ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma 		0.060 GeneticVariation disease BEFREE Association of G/A polymorphism, rs266882, in AREI region of the prostate-specific antigen gene with prostate cancer risk and clinicopathological features. 23235975 2012
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma 		0.060 Biomarker disease BEFREE Our study has indicated that the ratio of CB to SA is significantly higher in prostate cancer biopsy specimens than in BPH. 20392989 2010
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma 		0.060 GeneticVariation disease BEFREE With further research, such PSA-AREI polymorphism analyses may help in follow-up and in deciding the prognosis of prostate cancer patients. 19414393 2009
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma 		0.060 GeneticVariation disease BEFREE PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility. 17151093 2007
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma 		0.060 GeneticVariation disease BEFREE We found no evidence that risk of PCa is associated with the AR CAG, GGC, or PSA-158 AREI genetic polymorphisms in middle-aged Caucasian men. 15810021 2005
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma 		0.060 GeneticVariation disease BEFREE Our objective was to determine the relationship of CB and stefin A (cystatin A) mRNA localization to the Gleason grading system for histologic scores in the hope of distinguishing aggressive and less aggressive variants of prostate cancer. 10652560 2000